Baxalta remains key target for M&A hungry Shire
Shire’s CFO says a merger with Baxalta will offer significant operating and tax synergies as it continues to pursue the firm.
Archives for December 2, 2015
Novo Nordisk targets type 2 diabetes mAbs in Xoma licensing deal
Novo Nordisk has licensed the rights to Xoma’s monoclonal antibody insulin receptor activators in a deal potentially worth over $290m (€272m).
Cel-Sci adding more Multikine trial sites after recruitment slows
Cel-Sci says its CRO Ergomed has added more research sites to the Multikine Phase III study after patient enrolment slowed.
New liver cell production method will spark end of animal testing, scientist
An Israeli researcher says a cost-effective method for making human liver cells offers drug developers better safety evaluation and will “undoubtedly” replace animal testing.
Home-made pharmaceuticals may be possible in the near future
A homebrew engineer is raising society and ethical questions after designing an at-home bioreactor for pharmaceutical drugs.